Skip to main content

Table 2 Adverse events

From: FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study

Terms

N (%)

Grade 1

Grade 2

Grade 3

Grade 4

Anaemia

19 (44.2)

13 (30.2)

0

0

Neutropenia

4 (9.3)

8 (18.6)

3 (7.0)

0

Thrombocytopenia

9 (21.0)

3 (7.0)

0

0

Febrile neutropenia

0

0

Anorexia

4 (9.3)

3 (7.0)

2 (4.7)

0

Nausea

0

4 (9.3)

0

0

Vomiting

0

2 (4.7)

2 (4.7)

0

Peripheral sensory neuropathy

0

4 (9.3)

0

0

Diarrhoea

0

3 (7.0)

0

0

Malaise

1 (2.3)

0

1 (2.3)

0